The total return over the past 12 months is +39.19% vs. +23.67% for the S&P 500. So far it's up +39.13% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +36.80% | +20.38% | +10.20% | +10.77% | +10.87% | +7.02% |
| Total Return CAGR | +39.19% | +22.76% | +12.37% | +12.97% | +13.03% | +8.79% |
| Revenue CAGR | +9.87% | +6.80% | +0.89% | +4.42% | +3.01% | +3.38% |
| Net Income CAGR | +11.79% | +10.27% | (13.85%) | +2.56% | +3.14% | +3.42% |
| EPS CAGR | +12.63% | +2.99% | (3.65%) | +6.07% | +5.31% | +6.11% |
| Free Cash Flow CAGR | (0.33%) | +11.59% | (10.89%) | +5.76% | +3.83% | +2.79% |
| Operating Cash Flow CAGR | +5.72% | +8.89% | (7.32%) | +6.48% | +4.71% | +3.50% |
| Dividends CAGR | +6.42% | +6.60% | +7.35% | +7.92% | +14.75% | +11.69% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Quest Diagnostics Incorporated (DGX)
| Year | Start price | End price | DGX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $173.53 | $238.35 | +39.13% | +14.00% | +25.13% |
| 2025 | $150.86 | $173.53 | +17.21% | +17.72% | (0.51%) |
| 2024 | $137.88 | $150.86 | +11.78% | +24.89% | (13.11%) |
| 2023 | $156.44 | $137.88 | (10.06%) | +26.19% | (36.25%) |
| 2022 | $173.01 | $156.44 | (7.79%) | (18.17%) | +10.38% |
| 2021 | $119.17 | $173.01 | +47.86% | +28.74% | +19.12% |
| 2020 | $106.79 | $119.17 | +14.04% | +18.37% | (4.33%) |
| 2019 | $83.27 | $106.79 | +31.15% | +31.22% | (0.07%) |
| 2018 | $98.49 | $83.27 | (13.84%) | (4.56%) | (9.28%) |
| 2017 | $91.90 | $98.49 | +9.16% | +21.70% | (12.54%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
